A Phase 1 Study of VX-128 to Evaluate Single and Multiple Ascending Oral Doses of VX-128 In Healthy Volunteers

Trial Profile

A Phase 1 Study of VX-128 to Evaluate Single and Multiple Ascending Oral Doses of VX-128 In Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs VX 128 (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Vertex Pharmaceuticals
  • Most Recent Events

    • 19 Feb 2018 New trial record
    • 14 Feb 2018 According to a Vertex Pharmaceuticals media release, the company has recently initiated this study and will support the initiation of a Phase 2 study in acute pain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top